STUDI FARMAKOVIGILANS PENGOBATAN ASMA PADA PASIEN RAWAT INAP DI SUATU RUMAH SAKIT DI BOJONEGORO
Abstract: Asthma is a
respiratory disease with a large enough number of prevalence in the world.
Asthma treatmentin hospital needs serious monitoring because of the risk to
patient safety and increase the cost of treatment. One attempt to reduce the
incidence of unwanted is the pharmacovigilance studies to improve patient
safety.Purpose: to determine safety in terms of adverse drug reactions (ADR)
and drug interactions of the treatment of inpatient asthmatic patients in a
hospital.Methods: This is a non-experimental study with sampling using
purposive sampling. Then the data were obtained from medical records were
analyzed ADRs and drug interactions that occur using the library and shown
descriptively.Results: The study sample as many as 43 people. The results showed
there were 56 cases of ADRs on asthma medications, especially the use of
nebulized salbutamol (57.14%). While the incidence of asthma therapy drug
interactions there were 10 cases and the highest is aminophylline with
salbutamol (14.29%).Conclusion: Treatment of asthma need to get to the ADR
incidence and risk of drug interactions. Incidence of ADRs and drug
interactions at most of the use of salbutamol which is relatively safe
preference. This still needs to be done further research.
Keywords: asthma, adverse drug reactions, drug interaction,
pharmacovigilance
Penulis: Amelia Lorensia
Kode Jurnal: jpfarmasidd150513
